PL344573A1 - Novel formulation containing paroxetine - Google Patents
Novel formulation containing paroxetineInfo
- Publication number
- PL344573A1 PL344573A1 PL99344573A PL34457399A PL344573A1 PL 344573 A1 PL344573 A1 PL 344573A1 PL 99344573 A PL99344573 A PL 99344573A PL 34457399 A PL34457399 A PL 34457399A PL 344573 A1 PL344573 A1 PL 344573A1
- Authority
- PL
- Poland
- Prior art keywords
- formulation containing
- novel formulation
- containing paroxetine
- paroxetine
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810181.9A GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
PCT/GB1999/001520 WO1999058113A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL344573A1 true PL344573A1 (en) | 2001-11-05 |
Family
ID=10831927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99344573A PL344573A1 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1077682A2 (en) |
JP (1) | JP2002514591A (en) |
KR (1) | KR20010043574A (en) |
CN (1) | CN1308521A (en) |
AP (1) | AP2000002019A0 (en) |
AU (1) | AU3940999A (en) |
BG (1) | BG105010A (en) |
BR (1) | BR9910401A (en) |
CA (1) | CA2331871A1 (en) |
EA (1) | EA200001174A1 (en) |
GB (1) | GB9810181D0 (en) |
HU (1) | HUP0102064A2 (en) |
ID (1) | ID28019A (en) |
IL (1) | IL139594A0 (en) |
NO (1) | NO20005683L (en) |
PL (1) | PL344573A1 (en) |
SK (1) | SK17142000A3 (en) |
TR (1) | TR200003350T2 (en) |
WO (1) | WO1999058113A2 (en) |
ZA (1) | ZA200006562B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
HUP0401895A2 (en) * | 2001-10-22 | 2004-12-28 | Synthon B.V. | N-formyl derivatives of paroxetine, process for their preparation and pharmaceutical compositions containing them |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
NZ336587A (en) * | 1997-01-15 | 2001-01-26 | Smithkline Beecham P | Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran |
NZ505123A (en) * | 1997-12-19 | 2003-07-25 | Smithkline Beecham Corp | Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof |
-
1998
- 1998-05-13 GB GBGB9810181.9A patent/GB9810181D0/en not_active Ceased
-
1999
- 1999-05-13 BR BR9910401-6A patent/BR9910401A/en not_active Application Discontinuation
- 1999-05-13 HU HU0102064A patent/HUP0102064A2/en unknown
- 1999-05-13 KR KR1020007012706A patent/KR20010043574A/en not_active Application Discontinuation
- 1999-05-13 CN CN99808325A patent/CN1308521A/en active Pending
- 1999-05-13 AP APAP/P/2000/002019A patent/AP2000002019A0/en unknown
- 1999-05-13 ID IDW20002347A patent/ID28019A/en unknown
- 1999-05-13 TR TR2000/03350T patent/TR200003350T2/en unknown
- 1999-05-13 PL PL99344573A patent/PL344573A1/en unknown
- 1999-05-13 SK SK1714-2000A patent/SK17142000A3/en unknown
- 1999-05-13 IL IL13959499A patent/IL139594A0/en unknown
- 1999-05-13 WO PCT/GB1999/001520 patent/WO1999058113A2/en not_active Application Discontinuation
- 1999-05-13 EP EP99922302A patent/EP1077682A2/en not_active Withdrawn
- 1999-05-13 CA CA002331871A patent/CA2331871A1/en not_active Abandoned
- 1999-05-13 EA EA200001174A patent/EA200001174A1/en unknown
- 1999-05-13 JP JP2000547965A patent/JP2002514591A/en active Pending
- 1999-05-13 AU AU39409/99A patent/AU3940999A/en not_active Abandoned
-
2000
- 2000-11-10 NO NO20005683A patent/NO20005683L/en not_active Application Discontinuation
- 2000-11-13 ZA ZA200006562A patent/ZA200006562B/en unknown
- 2000-11-30 BG BG105010A patent/BG105010A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200001174A1 (en) | 2001-06-25 |
WO1999058113A3 (en) | 2000-02-17 |
IL139594A0 (en) | 2002-02-10 |
ZA200006562B (en) | 2002-02-13 |
GB9810181D0 (en) | 1998-07-08 |
SK17142000A3 (en) | 2001-06-11 |
TR200003350T2 (en) | 2001-03-21 |
BR9910401A (en) | 2001-01-09 |
CA2331871A1 (en) | 1999-11-18 |
AP2000002019A0 (en) | 2000-12-31 |
KR20010043574A (en) | 2001-05-25 |
EP1077682A2 (en) | 2001-02-28 |
WO1999058113A2 (en) | 1999-11-18 |
CN1308521A (en) | 2001-08-15 |
ID28019A (en) | 2001-05-03 |
BG105010A (en) | 2001-07-31 |
HUP0102064A2 (en) | 2002-05-29 |
NO20005683D0 (en) | 2000-11-10 |
JP2002514591A (en) | 2002-05-21 |
AU3940999A (en) | 1999-11-29 |
NO20005683L (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL341372A1 (en) | Cellecoxibe containing compositions | |
EP1016400A4 (en) | Composition for external use | |
PT1466615E (en) | Pharmaceutical composition | |
GB9809058D0 (en) | Composition | |
PL343769A1 (en) | Pharmaceutical composition | |
GB9818591D0 (en) | Pharmaceutical composition | |
GB9812119D0 (en) | Composition | |
PL334568A1 (en) | Paroxetin containing compositions | |
IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
GB9806788D0 (en) | Composition | |
IL136106A0 (en) | Formulations comprising dissolved paroxetine | |
GB9806793D0 (en) | Composition | |
IL139596A0 (en) | Novel formulation containing paroxetine | |
HK1044117B (en) | Pharmaceutical composition | |
IL138478A0 (en) | Paroxetine compositions | |
GB2331703B (en) | Disinfectant compositions | |
GB9809507D0 (en) | Novel composition | |
PL344573A1 (en) | Novel formulation containing paroxetine | |
GB9804041D0 (en) | Composition | |
GB9904523D0 (en) | Platinum (11) compounds | |
HU9800078D0 (en) | Pharmaceutical composition | |
GB9806791D0 (en) | Composition | |
GB9818910D0 (en) | Novel formulation | |
GB9818905D0 (en) | Novel formulation | |
GB9800011D0 (en) | Composition |